CICLOFILIN PHARMACEUTICALS
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and degenerative diseases. Ciclofilin Pharmaceuticals Inc. is comprised of a team of business, medical, and scientific professionals with decades of experience in pharmaceutical development. Our expertise in cyclosporins, the biopharmaceutic backbone of cyclophilin inhibitors, ideally positions Ciclofilin Pharmaceuticals to develop superior medications in this emerging drug class. Our head office is located in San Diego, California, with a R&D facility in Edmonton, Alberta.
CICLOFILIN PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ciclofilin.com
Total Employee:
1+
Status:
Active
Contact:
17809095041
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon ASP.NET IIS ASP.NET 4.0 IIS 7 NameBright
Official Site Inspections
http://www.ciclofilin.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ciclofilin Pharmaceuticals"
Ciclofilin Pharmaceuticals Corp - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ciclofilin Pharmaceuticals Corp of Edmonton, AB. Get the latest business insights from Dun & Bradstreet.See details»
Ciclofilin Pharmaceuticals - Ownership and Business Overview
Ciclofilin Pharmaceuticals, Inc. is a biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and โฆSee details»
Ciclofilin Pharmaceuticals - Products, Competitors, Financials ...
Headquarters Location. 12707 High Bluff Drive Suite 201. San Diego, California, 92130, United States. 619-701-5374See details»
Ciclofilin Pharmaceuticals Inc - Company Profile and News
The Company offers cyclophilin inhibitors, research, and therapeutic development services. Ciclofilin Pharmaceuticals markets its products in the United States and Canada. ...See details»
Company Information - RocketReach
A biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and degenerative diseases. Our Focus: Many โฆSee details»
Ciclofilin Pharmaceuticals - PitchBook
Ciclofilin Pharmaceuticals was acquired on 10-Jun-2016. Who acquired Ciclofilin Pharmaceuticals? Ciclofilin Pharmaceuticals was acquired by Hepion Pharmaceuticals. Data โฆSee details»
Ciclofilin Pharmaceuticals - Crunchbase
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors. New. Resources. Advanced Search. Start Free Trial . ... Experience the โฆSee details»
Ciclofilin Pharmaceuticals, Inc. (Ciclofilin Pharmaceuticals, Inc ...
EDISON, N.J., May 31, 2016 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted โฆSee details»
Ciclofilin Pharmaceuticals-Ciclofilin Pharmaceuticals Inc.-ไผไธ่ฏฆๆ ...
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and โฆSee details»
Ciclofilin Pharmaceuticals Announces Formation of - GlobeNewswire
SAN DIEGO, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. (See details»
Ciclofilin Pharmaceuticals acquired by Hepion Pharmaceuticals
May 31, 2016 Hepion Pharmaceuticals acquires Ciclofilin Pharmaceuticals on 2016-05-31 for $17000000. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. ...See details»
Press Release Distribution and Management - GlobeNewswire
SAN DIEGO, April 19, 2016 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a privately held biotech, announced today that it will discuss important new โฆSee details»
Ciclofilin Pharmaceuticals - CB Insights
Explore {Ciclofilin Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Ciclofilin โฆSee details»
Hepion Pharmaceuticals Acquires Ciclofilin Pharmaceuticals
On May 31, 2016, Hepion Pharmaceuticals acquired life science company Ciclofilin Pharmaceuticals for 17M USD Acquisition Highlights. This is Hepion Pharmaceuticalsโ 1st โฆSee details»
ContraVir expands hep B portfolio with Ciclofilin acquisition
May 31, 2016 Once the merger has been formally signed and sealed, Ciclofilin's founder and CEO Robert Foster will join ContraVir in the role of CSO, and will continue leading the โฆSee details»
Ciclofilin Pharmaceuticals Welcomes Dr. Nikolai Naoumov to
Feb 4, 2016 Ciclofilin is a privately held life sciences company based in San Diego, California, with R&D facilities in Edmonton, Canada. The company's lead drug candidate, CPI-431-32, is โฆSee details»
ContraVir Completes Merger with Ciclofilin Pharmaceuticals - PR โฆ
Jun 13, 2016 Ciclofilin's lead asset is CPI-431-32, which is in development against hepatitis B virus (HBV). CPI-431-32 strengthens ContraVir's HBV portfolio, which also contains CMX157, โฆSee details»
Ciclofilin Pharmaceuticals to Present HIV/HCV Co-Infection
Nov 4, 2014 Ciclofilin is developing a broad spectrum antiviral for the treatment of patients co-infected with hepatitis C ("HCV"), hepatitis B ("HBV") and HIV-1 viruses. Approximately 25% of โฆSee details»
Apolipoprotein E in Alzheimerโs disease: molecular insights and ...
3 days ago Apolipoprotein E (APOE-gene; apoE- protein) is a multifunctional protein involved in lipid transport, neuroinflammation, and neuronal repair, playing a crucial role in brain โฆSee details»
Ciclofilin Pharmaceuticals' HBV Drug Demonstrates - GlobeNewswire
Jun 24, 2015 Ciclofilin is a life sciences company based in San Diego, California, with R&D facilities in Edmonton, Canada. The company's lead drug, CPI-431-32, is uniquely designed to โฆSee details»